• ქართული
  • English
  • Bayer shares fall 10 percent after Monsanto's Roundup cancer trial

    Bayer shares plunged more than 10 percent on Monday after a California jury ordered the German company’s newly acquired Monsanto subsidiary to pay $289 million for not warning of cancer risks posed by its main weed killer.

    Market Quotes by TradingView